Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [41] Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI
    Li, Xin
    Huang, Wei
    Morris, Elizabeth A.
    Tudorica, Luminita A.
    Seshan, Venkatraman E.
    Rooney, William D.
    Tagge, Ian
    Wang, Ya
    Xu, Jingang
    Springer, Charles S., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (46) : 17937 - 17942
  • [42] Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer
    Wang, Weiwei
    Lv, Siqiang
    Xun, Jing
    Wang, Lei
    Zhao, Fan
    Wang, Jiehuan
    Zhou, Zhe
    Chen, Yueqin
    Sun, Zhanguo
    Zhu, Laimin
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [43] Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer
    Kabadi, Suraj J.
    Fatterpekar, Girish M.
    Anzai, Yoshimi
    Mogen, Jonathan
    Hagiwara, Mari
    Patel, Sohil H.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2018, 26 (01) : 135 - +
  • [44] Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes
    Youk, Ji Hyun
    Son, Eun Ju
    Chung, Jin
    Kim, Jeong-Ah
    Kim, Eun-kyung
    EUROPEAN RADIOLOGY, 2012, 22 (08) : 1724 - 1734
  • [45] Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes
    Ji Hyun Youk
    Eun Ju Son
    Jin Chung
    Jeong-Ah Kim
    Eun-kyung Kim
    European Radiology, 2012, 22 : 1724 - 1734
  • [46] Anatomical landmark localization in breast dynamic contrast-enhanced MR imaging
    Yin, X. X.
    Ng, B. W. -H.
    Yang, Q.
    Pitman, A.
    Ramamohanarao, K.
    Abbott, D.
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2012, 50 (01) : 91 - 101
  • [47] Anatomical landmark localization in breast dynamic contrast-enhanced MR imaging
    X. X. Yin
    B. W.-H. Ng
    Q. Yang
    A. Pitman
    K. Ramamohanarao
    D. Abbott
    Medical & Biological Engineering & Computing, 2012, 50 : 91 - 101
  • [48] Dynamic contrast-enhanced breast MR imaging in men: Preliminary results
    Morakkabati-Spitz, N
    Schild, HH
    Leutner, CC
    von Falkenhausen, M
    Lutterbey, G
    Kuhl, CK
    RADIOLOGY, 2006, 238 (02) : 438 - 445
  • [49] Gaussian Process Inference for Estimating Pharmacokinetic Parameters of Dynamic Contrast-Enhanced MR Images
    Wang, Shijun
    Liu, Peter
    Turkbey, Baris
    Choyke, Peter
    Pinto, Peter
    Summers, Ronald M.
    MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2012, PT III, 2012, 7512 : 582 - 589
  • [50] Translation of Dynamic Contrast Enhanced MRI in Head and Neck Cancer to the MR Linac
    Dubec, Michael J.
    Berks, Michael
    McDaid, Lisa
    Little, Ross A.
    Gaffney, John
    Price, James
    Cheung, Susan
    Porta, Nuria
    Matthews, Julian C.
    Choudhury, Ananya
    van Herk, Marcel
    McPartlin, Andrew
    Parker, Geoff J. M.
    Buckley, David L.
    O'Connor, James P. B.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S3824 - S3826